Mason Skinner, DO
Otolaryngology · Tulsa, OKNPI 1972000735
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 41.9% of the total.
Across 89 payments — averaging $46.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- Aerin Medical Inc.$710
- Regeneron Healthcare Solutions, Inc.$398
- Stryker$353
- Medtronic$343
- Sanofi$247
- plus $350 from 6 others
What the payments were for
- Food & beverage$4,131100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 34 | $1,730 |
| Aerin Medical Inc. | 15 | $710 |
| Regeneron Healthcare Solutions, Inc. | 13 | $398 |
| Stryker | 6 | $353 |
| Medtronic | 5 | $343 |
| Sanofi | 9 | $247 |
| Integra Lifesciences Corporation | 2 | $129 |
| Ambu Inc. | 1 | $117 |
| Boston Scientific | 1 | $32 |
| Baxter Healthcare | 1 | $26 |
| Acclarent, Inc | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$1,249
- VIVAER STYLUS$293
- RHINAER STYLUS$293
- STEALTHSTATION S8 PLATFORM$176
- MEDLINE INDUSTRIES, INC.$161
- PROPEL$133
- Acclarent Aera$113
- Inspira Air$113
- RELIEVA SPINPLUS NAV$113
- TruDi Probe$113
How this compares
$4,131 in reported general payments places this provider in the 80th percentile of 109 otolaryngology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $48,696 |
| Ipratropium Bromide | 207 | $5,305 |
| Fluticasone Propionate | 187 | $2,910 |
| Azelastine Hcl | 108 | $2,669 |
| Pantoprazole Sodium | 122 | $1,160 |
| Omeprazole | 40 | $884 |
| Ofloxacin | 25 | $877 |
| Azithromycin | 48 | $621 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 50 | $571 |
| Levocetirizine Dihydrochloride | 65 | $568 |
| Ondansetron OdtOndansetron | 32 | $255 |
| Mupirocin | 32 | $227 |
| Methylprednisolone | 27 | $211 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $133 |
| Triamcinolone Acetonide | 19 | $104 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Tulsa
- Lacy BrameTulsa$4K
- Landon MassothTulsa$4K
- William HawkinsTulsa$4K
- Jacob BurdettTulsa$3K
- David HallTulsa$3K
- Spencer VothTulsa$3K
- Benjamin BrownleeTulsa$2K
- Chris SiemensTulsa$2K
- Tom HamiltonTulsa$2K
- Evan MooreTulsa$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.